AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens

The purpose of the study is to define AroER tri-screen's utility for identifying endocrine-disrupting chemicals (EDCs) that target aromatase and/or estrogen receptor (ER), and to measure the total estrogenic activity in biological specimens. ER-positive, aromatase-expressing MCF-7 breast cancer...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Breast Cancer Res Treat
Egile Nagusiak: Kanaya, Noriko, Nguyen, Duc M., Lu, Hannah, Wang, Yuan-Zhong, Hsin, Li-Yu, Petreas, Myrto, Nelson, David, Guo, Weihong, Reynolds, Peggy, Synold, Tim, Chen, Shiuan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4591046/
https://ncbi.nlm.nih.gov/pubmed/25962693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3398-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak